The DOI matches its Crossref record; 45 of the 49 references it cites were found in a registry or an index.
A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration
Open accessAbstract
The neuronal ceroid lipofuscinoses (NCLs) constitute a group of neurodegenerative storage diseases characterized by progressive psychomotor retardation, blindness and premature death. Pathologically, there is accumulation of autofluorescent material in lysosome-derived organelles in a variety of cell types, but neurons in the central nervous system appear to be selectively affected and undergo progressive death. In this report we show that a novel form of NCL, congenital ovine NCL, is caused by a deficiency in the lysosomal aspartyl proteinase cathepsin D. A single nucleotide mutation in the cathepsin D gene results in conversion of an active site aspartate to asparagine, leading to production of an enzymatically inactive but stable protein. This results in severe cerebrocortical atrophy and early death, providing strong evidence for an important role of cathepsin D in neuronal development and/or homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CTSD is a ubiquitous protease, but its unique importance in brain is illustrated by the relatively selective neurodevelopmental and progressive neurodegenerative phenotype induced by the loss-of-function CTSD mutations causing the congenital disorder neuronal ceroid lipofuscinosis CLN10 (Tyynela ¨et al., 2000;Siintola et al., 2006).”
From Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-βCTF (C99) (2019) · cites this paper as Tyynela ¨et al., 2000
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
Handbook of Proteolytic Enzymes
(2004) · Elsevier eBooks · doi:10.1016/c2009-0-03628-9 · Cited by 2,623
[41] Cathepsin B, cathepsin H, and cathepsin L
Barrett, A. J., & Kirschke, H. (1981) · Methods in Enzymology · doi:10.1016/s0076-6879(81)80043-2 · Cited by 1,698
The Handbook of proteolytic enzymes
Barrett, A. J., Rawlings, N. D., & Woessner, J. F. (1998) · Cited by 1,119
Vesa, J., Hellsten, E., Verkruyse, L. A., Camp, L. A., Rapola, J., Santavuori, P., Hofmann, S. L., & Peltonen, L. (1995) · Nature · doi:10.1038/376584a0 · Cited by 736
The Structure and Function of the Aspartic Proteinases
Davies, D. R. (1990) · Annual Review of Biophysics and Biophysical Chemistry · doi:10.1146/annurev.bb.19.060190.001201 · Cited by 658
Isolation of a novel gene underlying batten disease, CLN3
Lerner, T. J., Boustany, R., Anderson, J. W., D'Arigo, K. L., Schlumpf, K. S., Buckler, A., Gusella, J. F., & Haines, J. L. (1995) · Cell · doi:10.1016/0092-8674(95)90274-0 · Cited by 598
Sleat, D. E., DONNELLY, R. J., Lackland, H., Liu, C., Sohár, I., Pullarkat, R. K., & Lobel, P. (1997) · Science · doi:10.1126/science.277.5333.1802 · Cited by 581
Self-citationSäftig, P., Hetman, M., Schmahl, W. W., Weber, K., Heine, L., Mossmann, H., Köster, A., Heß, B., Evers, M., & FIGURA, K. V. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00029.x · Cited by 439
The Presenilins in Alzheimer's Disease--Proteolysis Holds the Key
Haass, C., & Strooper, B. D. (1999) · Science · doi:10.1126/science.286.5441.916 · Cited by 388
Research works printed but not linked: 1
- Kohlshütter A and Lake BD (1999) NCL variants without genetic assignment. In Goebel,H.H., Mole,S.E. and Lake,B.D. (eds), Biomedical and Health Research, Vol. 33. IOS Press, Amsterdam, The Netherlands, pp. 125–127.
Cited by
Sorted by citations
Items 101–200 of 246
Nagakannan, P., Tabeshmehr, P., & Eftekharpour, E. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.04.001 · Cited by 41
Tardy, C., Tyynelä, J., Hasilík, A., Levade, T., & Andrieu‐Abadie, N. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401272 · Cited by 38
Self-citationPalmer, D. N. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.06.014 · Cited by 37
Yamasaki, R., Zhang, J., Koshiishi, I., Sastradipura, D. F. S., Wu, Z., Peters, C., Schwake, M., Uchiyama, Y., Kira, J., Säftig, P., et al. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.05.002 · Cited by 36
de Grey, A. D. N. J., Alvarez, P. J. J., Brady, R. O., Cuervo, A. M., Jerome, W. G., McCarty, P. L., Nixon, R. A., Rittmann, B. E., & Sparrow, J. R. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2005.03.008 · Cited by 38
Enhanced expression of manganese-dependent superoxide dismutase in human and sheep CLN6 tissues
Heine, C., Tyynelä, J., Cooper, J. D., Palmer, D. N., Elleder, M., Kohlschütter, A., & Braulke, T. (2003) · Biochemical Journal · doi:10.1042/bj20030598 · Cited by 36
Self-citationA Dictyostelium Mutant with Reduced Lysozyme Levels Compensates by Increased Phagocytic Activity
Müller, I., Šubert, N., Otto, H., Herbst, R., Rühling, H., Maniak, M., & Leippe, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411445200 · Cited by 35
The neuronal ceroid lipofuscinoses: Opportunities from model systems
Faller, K. M. E., Gutierrez‐Quintana, R., Mohammed, A., Rahim, A. A., Tuxworth, R. I., Wager, K., & Bond, M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.04.022 · Cited by 35
Homozygous PPT1 Splice Donor Mutation in a Cane Corso Dog With Neuronal Ceroid Lipofuscinosis
Kolicheski, A., Heller, H. B., Arnold, S. A., Schnabel, R. D., Taylor, J. F., Brookhart-Knox, C. A., Mhlanga-Mutangadura, T., O’Brien, D. P., Johnson, G. S., Dreyfus, J. M., et al. (2016) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.14632 · Cited by 34
Mizukami, K., Chang, H.-S., Yabuki, A., Kawamichi, T., Kawahara, N., Hayashi, D., Hossain, M. A., Rahman, M. M., Uddin, M. M., & Yamato, O. (2011) · Journal of Veterinary Diagnostic Investigation · doi:10.1177/1040638711425590 · Cited by 34
Koch, S., Molchanova, S. M., Wright, A. K., Edwards, A., Cooper, J. D., Taira, T., Gillingwater, T. H., & Tyynelä, J. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318238fc28 · Cited by 34
Self-citationMutka, A., Haapanen, A., Käkelä, R., Lindfors, M., Wright, A. K., Inkinen, T., Hermansson, M., Rokka, A., Corthals, G., Jauhiainen, M., et al. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06440.x · Cited by 34
Self-citationLysosomal Storage Diseases: Is Impaired Apoptosis a Pathogenic Mechanism?
Tardy, C., Andrieu‐Abadie, N., Salvayre, R., & Levade, T. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000021232.05175.38 · Cited by 32
Cathepsin D: Analysis of its potential role as an amyloid beta degrading protease
Gallwitz, L., Schmidt, L., Marques, A. R. A., Tholey, A., Cassidy, L., Ulku, I., Multhaup, G., Spiezio, A. D., & Säftig, P. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105919 · Cited by 34
Hirz, M., Drögemüller, M., Schänzer, A., Jagannathan, V., Dietschi, E., Goebel, H. H., Hecht, W., Laubner, S., Schmidt, M. J., Steffen, F., et al. (2016) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2016.12.007 · Cited by 31
Discovery and Early Clinical Development of LY3202626, a Low-Dose, CNS-Penetrant BACE Inhibitor
McKinzie, D. L., Winneroski, L. L., Green, S. J., Hembre, E. J., Erickson, J. A., Willis, B. A., Monk, S. A., Aluise, C. D., Baker, T. K., López, J. E., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00489 · Cited by 31
Siintola, E., Topçu, M., Kohlschütter, A., Salonen, T., Joensuu, T. H., Anttonen, A.-K., & Lehesjoki, A. (2005) · Clinical Genetics · doi:10.1111/j.1399-0004.2005.00471.x · Cited by 30
Palmer, D. N., Oswald, M. J., Westlake, V. J., & Kay, G. W. (2002) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(02)00011-0 · Cited by 30
Qiao, X., Lu, J.-Y., & Hofmann, S. L. (2007) · BMC Neuroscience · doi:10.1186/1471-2202-8-95 · Cited by 30
Steinfeld, R., Steinke, H.-B., Isbrandt, D., Kohlschütter, A., & Gärtner, J. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh264 · Cited by 30
Haapanen, A., Ramadan, U. A., Autti, T. H., Joensuu, R., & Tyynelä, J. (2007) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2007.03.012 · Cited by 29
Self-citationTyynelä, J., Sohár, I., Sleat, D. E., Gin, R. M., Nelly, R. J. D., Baumann, M., Haltia, M., & Lobel, P. (2001) · European Journal of Paediatric Neurology · doi:10.1053/ejpn.2000.0433 · Cited by 29
Self-citationThe history of progressive myoclonus epilepsies
Genton, P., Striano, P., & Minassian, B. A. (2016) · Epileptic Disorders · doi:10.1684/epd.2016.0834 · Cited by 29
Suopanki, J., Lintunen, M., Lahtinen, H., Haltia, M., Panula, P., Baumann, M., & Tyynelä, J. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0503 · Cited by 29
Self-citationCathepsin D in the Tumor Microenvironment of Breast and Ovarian Cancers
Pranjol, M. Z. I., & Whatmore, J. L. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43093-1_1 · Cited by 29
Lonka, L., Aalto, A., Kopra, O., Kuronen, M., Kokaia, Z., Saarma, M., & Lehesjoki, A. (2005) · BMC Neuroscience · doi:10.1186/1471-2202-6-27 · Cited by 28
Doccini, S., Sartori, S., Maeser, S., Pezzini, F., Rossato, S., Moro, F., Toldo, I., Przybylski, M., Santorelli, F. M., & Simonati, A. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8111-6 · Cited by 27
Payton, A., Boogerd, E. V. D., Davidson, Y. S., Gibbons, L., Ollier, W., Rabbitt, P., Worthington, J., Horan, M. A., & Pendleton, N. (2006) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2006.00191.x · Cited by 30
Koike, M., Shibata, M., Ezaki, J., Peters, C., Säftig, P., Kominami, E., & Uchiyama, Y. (2012) · European Journal of Neuroscience · doi:10.1111/ejn.12096 · Cited by 28
Neuronal ceroid lipofuscinosis in Australian Merino sheep: a new animal model
Tammen, I., Cook, R. W., Nicholas, F. W., & Raadsma, H. W. (2001) · European Journal of Paediatric Neurology · doi:10.1053/ejpn.2000.0432 · Cited by 27
Bernardini, F., & Warburton, M. J. (2002) · Biochemical Journal · doi:10.1042/bj20020467 · Cited by 27
Large Animal Models for Batten Disease
Weber, K. L., & Pearce, D. A. (2013) · Journal of Child Neurology · doi:10.1177/0883073813493666 · Cited by 26
Ketscher, A., Ketterer, S., Dollwet-Mack, S., REIF, U. M., & Reinheckel, T. (2015) · Biochimie · doi:10.1016/j.biochi.2015.07.020 · Cited by 26
Partanen, S., Storch, S., Löffler, H., Hasilík, A., Tyynelä, J., & Braulke, T. (2002) · Biochemical Journal · doi:10.1042/bj20021226 · Cited by 26
Self-citationCathepsin D deficiency induces cytoskeletal changes and affects cell migration pathways in the brain
Koch, S., Scifo, E., Rokka, A., Trippner, P., Lindfors, M., Korhonen, R., Corthals, G. L., Virtanen, I., Lalowski, M. M., & Tyynelä, J. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.10.004 · Cited by 25
Self-citationKnockdown of cathepsin D in zebrafish fertilized eggs determines congenital myopathy
Follo, C., Ozzano, M., Montalenti, C., Santoro, M. M., & Isidoro, C. (2013) · Bioscience Reports · doi:10.1042/bsr20120100 · Cited by 25
Lu, J.-Y., Verkruyse, L. A., & Hofmann, S. L. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00158-0 · Cited by 25
The neuronal ceroid-lipofuscinoses (Batten disease)
Mole, S., Schulz, A., & Haltia, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813866-3.00004-7 · Cited by 23
Self-citationThe function of CLN3P, the Batten disease protein
Rakheja, D., Narayan, S. B., & Bennett, M. J. (2008) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2008.01.001 · Cited by 23
Terron, H. M., Parikh, S. J., Abdul‐Hay, S. O., Sahara, T., Kang, D., Dickson, D. W., Säftig, P., LaFerla, F. M., Lane, S., & Leissring, M. A. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01443-6 · Cited by 22
Lysosomal proteomics and disease
Sleat, D. E., Jadot, M., & Lobel, P. (2007) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200700250 · Cited by 23
Self-citationMannose 6-Phosphorylated Proteins Are Required for Tumor Necrosis Factor-induced Apoptosis
Tardy, C., Autefage, H., Garcia, V., Levade, T., & Andrieu‐Abadie, N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408261200 · Cited by 22
Haskins, M. E., & Giger, U. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-370491-7.00024-6 · Cited by 22
Kumar, S., Briguglio, J. S., & Turkewitz, A. P. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-03-0833 · Cited by 20
Detection of procathepsin D in rat milk
Beneš, P., Koelsch, G., Dvořák, B., Fusek, M., & Větvička, V. (2002) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/s1096-4959(02)00112-4 · Cited by 20
Developmental Changes in the Expression of Neuronal Ceroid Lipofuscinoses-Linked Proteins
Suopanki, J., Partanen, S., Ezaki, J., Baumann, M., Kominami, E., & Tyynelä, J. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3071 · Cited by 20
Self-citationLeroy, J. G., Sillence, D. O., Wood, T. C., Barnes, J. W., Lebel, R. R., Friez, M. J., Stevenson, R. E., Steet, R., & Cathey, S. S. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.207 · Cited by 21
McLaren, M. D., Mathavarajah, S., Kim, W. D., Yap, S. Q., & Huber, R. J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.657406 · Cited by 19
Neuronal ceroid lipofuscinosis: underlying mechanisms and emerging therapeutic targets
Ziółkowska, E., Takahashi, K., Dickson, P., Sardiello, M., Sands, M. S., & Cooper, J. D. (2025) · Nature Reviews Neurology · doi:10.1038/s41582-025-01132-4 · Cited by 21
Kay, G. W., Jay, N. P., & Palmer, D. N. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.11.008 · Cited by 18
The neuronal ceroid-lipofuscinoses (Batten disease)
Mole, S., & Schulz, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19176-3.00018-2 · Cited by 19
Kopan, S., Sivasubramaniam, U., & Warburton, M. J. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.142 · Cited by 18
DNA Testing in Neurologic Diseases
O’Brien, D. P., & Leeb, T. (2014) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.12383 · Cited by 17
Analysis of NCL Proteins from an Evolutionary Standpoint
Muzaffar, N. E., & Pearce, D. A. (2008) · Current Genomics · doi:10.2174/138920208784139573 · Cited by 17
Experimental approaches for altering the expression of Abeta‐degrading enzymes
Loeffler, D. A. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15762 · Cited by 18
Cronin, G. M., Beganovic, D. F., Sutton, A. L., Palmer, D. J., Thomson, P. C., & Tammen, I. (2015) · Applied Animal Behaviour Science · doi:10.1016/j.applanim.2015.11.012 · Cited by 17
Katz, M. L., Buckley, R. M., Biegen, V. R., O’Brien, D. P., Johnson, G. C., Warren, W. C., & Lyons, L. A. (2020) · G3 Genes Genomes Genetics · doi:10.1534/g3.120.401407 · Cited by 15
Tsukamoto, T., Iida, J., Dobashi, Y., Furukawa, T., & Konishi, F. (2006) · Cancer · doi:10.1002/cncr.21764 · Cited by 15
Another disorder finds its gene
Ramirez‐Montealegre, D. (2006) · Brain · doi:10.1093/brain/awl132 · Cited by 16
Primary defects in lysosomal enzymes
WINCHESTER, B. G. (2004) · doi:10.1093/acprof:oso/9780198508786.003.0004 · Cited by 15
Cho, S. K., & Hofmann, S. L. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.2.302-310.2004 · Cited by 14
Neuronal ceroid-lipofuscinoses
Rakheja, D., & Bennett, M. J. (2018) · Translational Science of Rare Diseases · doi:10.3233/trd-180024 · Cited by 14
Kuronen, M., Talvitie, M., Lehesjoki, A., & Myllykangas, L. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.09.001 · Cited by 14
Cathepsin D: A Candidate Link between Amyloid ?-protein and Tauopathy in Alzheimer Disease
Suire, C. N., & Leissring, M. A. (2021) · Journal of Experimental Neurology · doi:10.33696/neurol.2.029 · Cited by 15
Xu, S., Sleat, D. E., Jadot, M., & Lobel, P. (2010) · Biochemical Journal · doi:10.1042/bj20100128 · Cited by 13
Self-citationPicrotoxin-induced convulsions and lysosomal function in the rat brain
Acharya, M. M., Khamesra, S. H., & Katyare, S. S. (2005) · Indian Journal of Clinical Biochemistry · doi:10.1007/bf02893043 · Cited by 13
Haematopoietic development and immunological function in the absence of cathepsin D
Tulone, C., Uchiyama, Y., Novelli, M. R., Grosvenor, N., Säftig, P., & Chain, B. (2007) · BMC Immunology · doi:10.1186/1471-2172-8-22 · Cited by 13
Cathepsins: Getting in Shape for Lysosomal Proteolysis
Erickson, A. H., Isidoro, C., Mach, L., & Mort, J. S. (2013) · Springer eBooks · doi:10.1007/978-3-7091-0885-7_4 · Cited by 14
Démoz, M., Castino, R., Follo, C., Hasilík, A., Sloane, B. F., & Isidoro, C. (2005) · Protein Expression and Purification · doi:10.1016/j.pep.2005.07.024 · Cited by 13
Rajan, I., Read, R. W., Small, D. L., Perrard, J., & Vogel, P. (2010) · Veterinary Pathology · doi:10.1177/0300985810370164 · Cited by 12
Bioinformatic perspectives in the neuronal ceroid lipofuscinoses
Kmoch, S., Stránecký, V., Emes, R. D., & Mitchison, H. M. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.12.010 · Cited by 12
Cathepsin Deficiency as a Model for Neuronal Ceroid Lipofuscinoses
Shacka, J. J., & Roth, K. A. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61233-3 · Cited by 12
Lysosomal storage disease associated with a CNP sequence variant in Dalmatian dogs
Bullock, G., Johnson, G. S., Mhlanga-Mutangadura, T., Petesch, S. C., Thompson, S., Goebbels, S., & Katz, M. L. (2022) · Gene · doi:10.1016/j.gene.2022.146513 · Cited by 11
Characterization of Neuronal Ceroid-Lipofuscinosis in 3 Cats
Chalkley, M., Armién, A. G., Gilliam, D., Johnson, G. S., Zeng, R., Wünschmann, A., Kovi, R. C., & Katz, M. L. (2013) · Veterinary Pathology · doi:10.1177/0300985813502818 · Cited by 11
Batten disease through different in vivo and in vitro models: A review
Nittari, G., Tomassoni, D., Roy, P., Martinelli, I., Tayebati, S. K., & Amenta, F. (2022) · Journal of Neuroscience Research · doi:10.1002/jnr.25147 · Cited by 10
Genetic testing for phenotype-causing variants in sheep and goats
Lühken, G. (2012) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2012.04.005 · Cited by 13
Neuronal Ceroid Lipofuscinosis in a Vietnamese Pot-bellied Pig (Sus scrofa)
Cesta, M. F., Mozzachio, K., Little, P. B., Olby, N. J., Sills, R. C., & Brown, T. T. (2006) · Veterinary Pathology · doi:10.1354/vp.43-4-556 · Cited by 10
Nibe, K., Miwa, Y., Matsunaga, S., CHAMBERS, J. K., Uetsuka, K., Nakayama, H., & Uchida, K. (2011) · Veterinary Pathology · doi:10.1177/0300985811400441 · Cited by 10
Lorenz, M. D., Coates, J. R., & Kent, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0651-2.10015-3 · Cited by 9
Characterization of Candidate Genes for Neuronal Ceroid Lipofuscinosis in Dog
Drögemüller, C., Wöhlke, A., & Distl, O. (2005) · Journal of Heredity · doi:10.1093/jhered/esi088 · Cited by 9
Genetic polymorphism in exon 2 of cathepsin D is not associated with vascular dementia
Jeong, B., Lee, K.-H., Lee, Y.-J., Yun, J., Park, Y.-J., Kim, Y.-H., Cho, Y.-S., Choi, E., Carp, R. I., & Kim, Y. (2010) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2010.01400.x · Cited by 7
Follo, C., Ozzano, M., Montalenti, C., Ekkapongpisit, M., & Isidoro, C. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.10.010 · Cited by 7
Neuronal Ceroid-Lipofuscinoses
Tyynelä, J. (2007) · Springer eBooks · doi:10.1007/0-387-28957-7_8 · Cited by 7
Self-citationGene Arrays, Cell Lines, Stem Cells, and Sensory Regeneration in Mammalian Ears
Rivolta, M. N., & Holley, M. C. (2008) · Springer eBooks · doi:10.1007/978-0-387-73364-7_7 · Cited by 6
Translating preclinical models of neuronal ceroid lipofuscinosis: progress and prospects
Nelvagal, H. R., & Cooper, J. D. (2017) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2017.1360182 · Cited by 6
The canine CTSD gene as a candidate for late‐onset neuronal ceroid lipofuscinosis
Wöhlke, A., Distl, O., & Drögemüller, C. (2005) · Animal Genetics · doi:10.1111/j.1365-2052.2005.01375.x · Cited by 6
Neuronal Ceroid Lipofuscinosis in a Mallard Duck (Anas platyrhynchos)
Evans, E. E., Jones, M. P., Crews, A., & Newkirk, K. M. (2012) · Journal of Avian Medicine and Surgery · doi:10.1647/2010-045.1 · Cited by 6
Conner, G. E. (2004) · Handbook of Proteolytic Enzymes · doi:10.1016/b978-0-12-079611-3.50016-1 · Cited by 6
Neuronal Ceroid-Lipofuscinoses
Rakheja, D., & Bennett, M. J. (2017) · IOS Press eBooks · doi:10.3233/978-1-61499-718-4-499 · Cited by 5
The Impact of Assay Design on Medicinal Chemistry: Case Studies
Born, J. R., Chenniappan, V. K., Davis, D., Dahlin, J. L., Marugán, J., & Patnaik, S. (2021) · SLAS DISCOVERY · doi:10.1177/24725552211026238 · Cited by 5
A one-health approach to using sheep in research, with a focus on neuroscience studies
Chatzimanou, T., & Tsingotjidou, A. (2023) · One Health & Implementation Research · doi:10.20517/ohir.2023.13 · Cited by 3
Role of altered pH homeostasis and hypoxia in the phenotypic changes of cancer cells
Kokkonen, N. (2009) · Cited by 4
Neuronal ceroid lipofuscinosis in a Schapendoes dog is caused by a missense variant in CLN6
Bellamy, K. K. L., Skedsmo, F. S., Hultman, J., Jansen, J. H., & Lingaas, F. (2024) · Animal Genetics · doi:10.1111/age.13457 · Cited by 3
Gansz, M., Kern, U., Peters, C., & Reinheckel, T. (2013) · Springer eBooks · doi:10.1007/978-3-7091-0885-7_6 · Cited by 3
Suzuki, K., & Suzuki, K. (2008) · CRC Press eBooks · doi:10.1201/b13319-8 · Cited by 3
Identifying Targets in α‐Synuclein Metabolism to Treat Parkinson Disease and Related Disorders
Tomlinson, J. J., Cullen, V., & Schlossmacher, M. G. (2010) · doi:10.1002/9780470572702.ch37 · Cited by 3
Neuronale Zeroidlipofuszinosen (NCL) im Tiermodell
Rüther, K. (2010) · Der Ophthalmologe · doi:10.1007/s00347-009-2108-9 · Cited by 2
Detection of cathepsin D in ewe’s milk by Western Blotting method
Špehar, I. D., Martinković, F., Havranek, J., Marinculić, A., Kalit, M. T., & Kalit, S. (2013) · Hrčak Portal of scientific journals of Croatia (University Computing Centre) · Cited by 2
Neuronal ceroid lipofuscinosis/Batten disease: the lysosomal proteinoses
Gupta, P. K., & Hofmann, S. L. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001127 · Cited by 2
Lysosomal Membrane Transport in the Central Nervous System
Morin, P., Sagné, C., & Gasnier, B. (2007) · Springer eBooks · doi:10.1007/978-0-387-30380-2_22 · Cited by 2
Metadata
- Authors
- Tyynelä, J., Sohar, I., Sleat, D. E., Gin, R. M., Donnelly, R. J., Baumann, M., Haltia, M., & Lobel, P.
- Affiliations
- University of Helsinki (FI)
- Rutgers, The State University of New Jersey (US)
- Rutgers New Jersey Medical School (US)
- Corresponding author
- Tyynelä, Jaana
- Lobel, Peter
- Venue
- The EMBO Journal
- Published
- 2000-06-15
- Volume
- 19
- Issue
- 12
- Pages
- 2786-2792
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC203370
- OpenAlex
- W2040107841
- Cited by
- 245
- References
- 49
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 5 · 2023: 2 · 2022: 6 · 2021: 4 · 2020: 7 · 2019: 5 · 2018: 2 · 2017: 5 · 2016: 10 · 2015: 7 · 2014: 5 · 2013: 12 · 2012: 14
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The EMBO Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Lastentautien Tutkimussäätiö
- National Institutes of Health (5r01dk045992-08)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-54317, DK-45992, R01DK054317)
- National Institute of Neurological Disorders and Stroke (NS-37918, R01NS037918)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Health Sciences › Medicine › Nephrology › Biomedical Research and Pathophysiology
- Keywords
- neuronal ceroid lipofuscinosis, cathepsin D, lysosomal storage disease, neurodegeneration, sheep model, point mutations, lysosomal protein degradation, neuronal development
- MeSH terms
- Amino Acid Sequence, Animals, Cathepsin D, Liver, Lysosomes, Molecular Sequence Data, Mutation, Neuronal Ceroid-Lipofuscinoses, Sheep, Sequence Homology, Amino Acid, Lysosomal Storage Diseases, Nervous System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review